FDA Approves First Immunotherapy Drug for Breast Cancer
Combo of Tecentriq and chemo given accelerated approval for triple-negative breast cancer
Only About Half of Elderly Newly Diagnosed With ALL Receive Tx
53.5 percent receive treatment within 90 days; 32.4 percent receive chemo without tyrosine kinase inhibitors
Genetic Testing Recommended for All Patients With Breast Cancer
All with personal history of breast cancer should be offered testing; updated testing recommended
American Academy of Dermatology, March 1-5
The American Academy of Dermatology The annual meeting of the American Academy of Dermatology was held from March 1 to 5 in Washington,...
Becoming Active in Middle Age Still Offers Health Benefits
Lower risk for all-cause, cardiovascular, cancer-related mortality similar to people active throughout adulthood
Recall Down, Cancer Detection Up With Digital Breast Tomosynthesis
Breast cancers detected by DBT less often classified as having poor prognosis than those identified by DM
Electronic Order Set May Reduce Inappropriate ECG Monitoring
Findings observed among hospitalized patients not in an intensive care unit
Preoperative Frailty Linked to Surgical Outcomes, Costs
Incidence of major morbidity, readmission, mortality correlated with frailty classification
Stereotactic Body RT Promising for Low-, Intermediate-Risk PCa
Stereotactic body radiotherapy linked to low rates of severe toxic events, high rates of biochemical control
Childhood Cancer Considerably Underdiagnosed Worldwide
Numbers of undiagnosed cases varied from 3 percent in western Europe to 57 percent in western Africa
